Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases

dc.authorid0000-0002-0159-2090
dc.authorid0000-0001-8014-2321
dc.contributor.authorBalaban, Muhsin
dc.contributor.authorÖzkaptan, Orkunt
dc.contributor.authorSevinç, Cüneyd
dc.contributor.authorBoz, Mustafa Yücel
dc.contributor.authorHoruz, Rahim
dc.contributor.authorKafkaslı, Alper
dc.contributor.authorCangücen, Önder
dc.date.accessioned2020-01-08T08:18:11Z
dc.date.available2020-01-08T08:18:11Z
dc.date.issued2020
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı
dc.description.abstractObjectives: To investigate the characteristics of cases of NIH category I acute prostatitis developed after transrectal prostate biopsy and clarifiy the risk factors and preventive factors. Materials and Methods: We retrospectively reviewed the medical records of 3.479 cases of transrectal ultrasound-guided needle biopsies performed with different prophylactic antibiotherapy regimens at two different institutions between January 2011 and February 2016. The patients of Group I have received ciprofloxacin (n=1.523, 500mg twice daily) and the patients of Group II have received ciprofloxacin plus ornidazole (n=1.956, 500mg twice daily) and cleansing enema combination as prophylactic antibiotherapy. The incidence, clinical features and other related microbiological and clinical data, were evaluated. Results: Mean age was 62.38 +/- 7.30 (47-75), and the mean prostate volume was 43.17 +/- 15.20 (21-100) mL. Of the 3.479 patients, 39 (1.1%) developed acute prostatitis after the prostate biopsy procedure. Of the 39 cases of acute prostatitis, 28/3.042 occurred after the first biopsy and 11/437 occurred after repeat biopsy (p=0.038). In Group I, 22 of 1.523 (1.4%) patients developed acute prostatitis. In Group II, 17 of 1.959 (0.8%) patients developed acute prostatitis. There was no statistical difference between the two groups according to acute prostatitis rates (X2=2.56, P=0.11). Further, hypertension or DM were not related to the development of acute prostatitis (P=0.76, X2=0.096 and P=0.83, X2=0.046, respectively). Conclusions: Repeat biopsy seems to increase the risk of acute prostatitis, while the use of antibiotics effective for anaerobic pathogens seems not to be essential yet.
dc.identifier.citationBalaban, M., Özkaptan, O., Sevinç, C., Boz, M. Y., Horuz, R., Kafkaslı, A. ve Cangüven, Ö. (2020). Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases. International Braz J Urol, 46(1), 60-66. https://doi.org/10.1590/S1677-5538.IBJU.2019.0257
dc.identifier.doi10.1590/S1677-5538.IBJU.2019.0257
dc.identifier.endpage66
dc.identifier.issn1677-5538
dc.identifier.issn1677-6119
dc.identifier.issue1
dc.identifier.scopusqualityQ3
dc.identifier.startpage60
dc.identifier.urihttps://doi.org/10.1590/S1677-5538.IBJU.2019.0257
dc.identifier.urihttps://hdl.handle.net/20.500.12511/4893
dc.identifier.volume46
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBrazilian Society of Urology
dc.relation.ispartofInternational Braz J Urolen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectAcute Bacterial Prostatitis
dc.subjectSpectrum Beta-Lactamase
dc.subjectAntibiotic-Prophylaxis
dc.subjectNeedle-Bopsy
dc.subjectAnaerobic Infection
dc.subjectSingle
dc.subjectFluoroquinolone
dc.subjectComplications
dc.subjectResistance
dc.titleAcute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Boz, Mustafa Yücel-2020.pdf
Boyut:
514.62 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text